FDA Drug recall D-318-2013
Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0…
- FDA Drug
- Class III
- terminated
- Published 2013-05-15
On 2013-05-15 the FDA classified a Class III recall of Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0… by L Perrigo, citing failed Impurities/Degradation Specifications: 3 month stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-318-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-03-12 |
| Published | 2013-05-15 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | L Perrigo |
| Distribution | US |
Product
Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,
Reason
Failed Impurities/Degradation Specifications: 3 month stability testing.
Identifiers
| code_info | 12K714 exp. 12/13, 12K715 exp. 12/13 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-318-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.